References
- Acharya J, Dubey DK, Srivastava AK, Raza SK. (2011). In vitro reactivation of sarin-inhibited human acetylcholinesterase (AChE) by bis-pyridinium oximes connected by xylene linkers. Toxicol in Vitro 25:251–6.
- Allen TM, Hansen CB, de Menezes DEL. (1995). Pharmacokinetics of long-circulating liposomes. Adv Drug Delivery Rev 16:267–84.
- Cassel GE, Fosbraey P. (1996). Measurement of the oxime HI-6 after peripheral administration in tandem with neurotransmitter levels in striatal dialysates: effects of soman intoxication. J Pharmacol Toxicol Methods 35:159–66.
- Dadparvar M, Wagner S, Wien S, et al. (2014). Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability. Eur J Pharm Biopharm 88:510–7.
- Deodhar S, Dash AK. (2018). Long circulating liposomes: challenges and opportunities. Ther Deliv 9:857–72.
- Diauudin FN, Rashid JIA, Knight VF, et al. (2019). A review of current advances in the detection of organophosphorus chemical warfare agents based biosensor approaches. Sens Bio-Sens Res 26:100305.
- Gupta B, Ghosh KK. (2013). Evaluation of biological efficiency of oxime based reactivators against organophosphate inhibited AChE: an in vitro study. Toxicol Lett 221:S147–S148.
- Hulse EJ, Haslam JD, Emmett SR, Woolley T. (2019). Organophosphorus nerve agent poisoning: managing the poisoned patient. Br J Anaesth 123:457–63.
- John H, Thiermann H. (2021). Poisoning by organophosphorus nerve agents and pesticides: an overview of the principle strategies and current progress of mass spectrometry-based procedures for verification. J Mass Spectrom Adv Clin Lab 19:20–31.
- Kloske M, Witkiewicz Z. (2019). Novichoks – the A group of organophosphorus chemical warfare agents. Chemosphere 221:672–82.
- Koplovitz I, Stewart JR. (1994). A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit. Toxicol Lett 70:269–79.
- Kovarik Z, Macek N, Sit RK, et al. (2013). Centrally acting oximes in reactivation of tabun-phosphoramidated AChE. Chem Biol Interact 203:77–80.
- Kuca K, Cabal J, Jun D, et al. (2010). Reactivation of VX-inhibited AChE by novel oximes having two oxygen atoms in the linker. Environ Toxicol Pharmacol 30:85–7.
- Ligtenstein DA, Kossen SP. (1983). Kinetic profile in blood and brain of the cholinesterase reactivating oxime HI-6 after intravenous administration to the rat. Toxicol Appl Pharmacol 71:177–83.
- Lundy PM, Hill I, Lecavalier P, et al. (2005). The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning. Toxicology 208:399–409.
- Marjan JM, Allen TM. (1996). Long circulating liposomes: past, present and future. Biotechnol Adv 14:151–75.
- Meads KL, Thomas TP, Langston JL, et al. (2021). Evaluation of adenosine A1 receptor agonists as neuroprotective countermeasures against Soman intoxication in rats. Toxicol Appl Pharmacol 416:115466.
- Myhrer T, Mariussen E, Aas P. (2018). Development of neuropathology following soman poisoning and medical countermeasures. Neurotoxicology 65:144–65.
- Pinho JO, da Silva IV, Amaral JD, et al. (2021). Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management. Int J Pharm 599:120463.
- Reymond C, Jaffre N, Taudon N, et al. (2018). Superior efficacy of HI-6 dimethanesulfonate over pralidoxime methylsulfate against Russian VX poisoning in cynomolgus monkeys (Macaca fascicularis). Toxicology 410:96–105.
- Singh A, Ujjwal RR, Naqvi S, et al. (2022). Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease. J Drug Target 30:777–91.
- Sun W-X, Zhang C-T, Yu X-N, et al. (2022). Preparation and pharmacokinetic study of diosmetin long-circulating liposomes modified with lactoferrin. J Funct Foods 91:105027.